Annual Drug Patent Expirations for ANORO+ELLIPTA Anoro Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. […]
New patent expiration for Glaxosmithkline drug ANORO ELLIPTA Read Post »
Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in
New patent expiration for Glaxo Grp drug BREO ELLIPTA Read Post »
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA.
New patent expiration for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »
Annual Drug Patent Expirations for ORAVIG Oravig is a drug marketed by Galt Pharms and is included in one NDA.
New patent expiration for Galt Pharms drug ORAVIG Read Post »
Annual Drug Patent Expirations for VANOS Vanos is a drug marketed by Bausch and is included in one NDA. It
Annual Drug Patent Expirations for LONHALA+MAGNAIR+KIT Lonhala Magnair Kit is a drug marketed by Sunovion Resp and is included in
New patent expiration for Sunovion Resp drug LONHALA MAGNAIR KIT Read Post »
Annual Drug Patent Expirations for DEXYCU+KIT Dexycu Kit is a drug marketed by Eyepoint Pharms and is included in one
New patent expiration for Eyepoint Pharms drug DEXYCU KIT Read Post »
LONHALA MAGNAIR KIT (glycopyrrolate) Sunovion resp Patent: 7,316,067 Expiration: Sep 6, 2022 See More … For more information on how
Drug Patent Expirations for the Week of September 4, 2022 Read Post »
Annual Drug Patent Expirations for BYLVAY Bylvay is a drug marketed by Albireo and is included in one NDA. There
Get fresh news and insights, drug patent expirations & more…
